Director exercised or converted 748K ROIV derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Dec 29, 2025
- Reporting period
- Not applicable
- Filed with the SEC
- Jan 1, 2026
DirectorOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0001140361-25-047122
Filed / recordedJan 1, 2026, 7:00 AM UTCAdded to OQROOct 6, 2026, 8:46 PM UTC Data qualityVerified: identifiers matched exactly IssuerRoivant Sciences Ltd. Reporting personMayukh Sukhatme RelationshipDirector, Officer Officer titlePresident & CIO SecurityStock Option (Right to Buy) TableDerivative (Table II) Transaction dateDec 29, 2025 Acquired / disposedDisposed (D) Shares owned after555,840 Footnotes from the filing
- Award of stock options to purchase Common Shares that is fully vested.
Around the same time
Traded Jan 20 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.
Traded Jan 20 · filed 3 days later
Routine share withholding; mechanical by default.
Traded Jan 20 · filed 3 days later
Compensation award — excluded from discretionary-purchase analysis.